A Year In Review – Our Top Blogs from 2017
As snow starts to fall across the country and temperatures decline, winter and 2018 are here! 2017 was a busy year for the healthcare industry, from the new administration, ground breaking treatment advancements, the potential of artificial intelligence and most recently, the CVS and Aetna health merger. 2017 has also been a busy year for us at MedeAnalytics with new hires, customer announcements, speaking sessions and more! As we gear up for the new year, we’re looking back and highlighting our top three blog posts from 2017:
Meet MedeAnalytics’ new CEO, Paul Kaiser – In May, we were excited to announce our new CEO, Paul Kaiser, and in June, we had a chance to connect with him to learn more about his background, his company observations thus far and his future plans for the company. Our blog outlines the opportunities our CEO sees for Mede clients and how we can continue to support them amidst the everchanging healthcare landscape.
Enterprise Analytics and Beyond: A Q&A with our Vice President of Healthcare Provider Solutions – In March, our blog explored top provider concerns and offered insight from a Mede executive on the challenges that lay ahead and continued importance of investing in an Enterprise Analytics (EA) strategy. The post outlined proactive approaches for providers to take to ensure a seamless EA strategy, including training and educating clinical leadership, establishing realistic goals and empowering self-service. The post concluded by outlining how analytics’ role in reporting and identifying care and cost improvement opportunities will only grow in importance in the years ahead.
Driving Enterprise-Wide Change by Breaking Down Data Silos and Creating a Data-Driven Culture – At this year’s Big Data & Healthcare Analytics Forum MedeAnalytics’ client, Soyal Momin, Vice President of Data & Analytics at Presbyterian Healthcare Services, discussed how, thanks to a partnership with MedeAnalytics, the organization was able to harness their data and adopt a data-driven culture across their organization. During his presentation, Soyal outlined how the approach promoted outcome-driven clinical excellence and allowed the organization to achieve ROI in the clinical, operational and financial areas within their enterprise. Soyal will also be speaking at HIMSS18 this year and we can’t wait to hear his presentation!
2018 will bring a lot of exciting changes to both the healthcare industry and MedeAnalytics! Make sure to stay up to date on industry and Mede happenings via our blog and follow us on Twitter and LinkedIn. Interested in learning how MedeAnalytics can support your organization in the new year? Contact us here.
Get our take on industry trends
Crystal ball not necessary: predictive analytics helps health systems reduce denials
The idea of having a crystal ball to better understand what claims will be denied is an awesome concept. But one we can’t rely on. Thankfully, we have predictive analytics to take the place of a crystal ball.
Read on...
How did we get here? Hospital analytics and the new normal
I have heard the word “unprecedented” so many times in 2020 that it has lost its significance; many of us have become desensitized to the extraordinary changes in the world this year.
Read on...
How to help employer groups plan in a time of uncertainty
Employers and their sponsored health plans are thinking about next year’s benefit designs with a significant challenge not seen before: the effect of the coronavirus pandemic. There are important considerations to take into account before making any decisions about new or existing coverage. Becky Niehus, a director of Product Consulting at MedeAnalytics, explores these new issues and what employers can do to ensure employees are “covered.”
Read on...
Healthcare’s return to “normal” after COVID-19: Is it possible?
As providers determine how to get patients to return to facilities for routine disease management and preventive screenings, opportunities are ripe for the application of analytics to triage at the right time to the right setting. Data related to COVID-19 will continue to flow rapidly, but there are possibly more questions than answers now about a return to “normal.”
Read on...